Sirio Pharma Co.,Ltd.’s Net Profit Dropped 24.6% in First Half of 2022

Sirio Pharma Co.,Ltd. (仙乐健康科技股份有限公司) (300791.SZ) reported a net profit of 109.9 million yuan in the first half of 2022, down 24.6% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, down 4.6% year-on-year.

At the end of the reporting period, it had 4 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 34.6%.